DR. WILLIAM MICHAEL PANDAK, M.D.
Osteopathic Medicine at Favero Rd, Richmond, VA
License number
Virginia 0101036958
Category
Osteopathic Medicine
Type
Gastroenterology
Address
Address
3724 Favero Rd, Richmond, VA 23233
Phone
(804) 675-5021
(804) 675-5816 (Fax)
(804) 360-0672
(804) 675-5816 (Fax)
(804) 360-0672
Personal information
See more information about WILLIAM MICHAEL PANDAK at radaris.comName
Address
Phone
11230 Edgemoor Ct, Woodbridge, VA 22192
3724 Favero Rd, Richmond, VA 23233
Staunton, VA
306 Rainbow Dr, Staunton, VA 24401
3724 Favero Rd, Richmond, VA 23233
Professional information
See more information about WILLIAM MICHAEL PANDAK at trustoria.com
Nuclear Sulfated Oxysterol, Potent Regulator Of Cholesterol Homeostasis, For Therapy Of Hypercholesterolemia, Hyperlipidemia, And Atherosclerosis
Nuclear Sulfated Oxysterol, Potent Regulator Of Cholesterol Homeostasis, For Therapy Of Hypercholesterolemia, Hyperlipidemia, And Atherosclerosis
US Patent:
2007027, Nov 29, 2007
Filed:
Apr 24, 2007
Appl. No.:
11/739330
Inventors:
Shunlin Ren - Richmond VA, US
William Pandak - Richmond VA, US
William Pandak - Richmond VA, US
International Classification:
A61K 31/56, C07J 9/00
US Classification:
514169000, 552540000
Abstract:
The sulfated oxysterol 5-cholesten-3β, 25-diol 3-sulphate, a nuclear steroid metabolite that increases cholesterol secretion and degradation, is provided as an agent to lower intracellular and serum cholesterol and/or triglycerides. Methods which involve the use of this sulfated oxysterol to treat conditions associated with high cholesterol and/or high triglycerides (e.g. hypercholesterolemia, hyperlipidemia, and atherosclerosis) are also provided.
Antitryptase Autoantibody-Tryptase Immune Complex As A Unique Marker For Diagnosis And As A Potential Target For Therapy Of Immediate Hypersensitivity Diseases
Antitryptase Autoantibody-Tryptase Immune Complex As A Unique Marker For Diagnosis And As A Potential Target For Therapy Of Immediate Hypersensitivity Diseases
US Patent:
2003009, May 15, 2003
Filed:
Jan 29, 2002
Appl. No.:
10/060545
Inventors:
William Pandak - Richmond VA, US
Hae Min - Richmond VA, US
Shunlin Ren - Richmond VA, US
Hae Min - Richmond VA, US
Shunlin Ren - Richmond VA, US
Assignee:
PAX BIOGEN CO., LTD.
International Classification:
G01N033/53, G01N033/537, G01N033/543
US Classification:
435/007930
Abstract:
The disclosure describes the presence of antitryptase autoantibody-tryptase immune complexes (the immune complexes) in sera of patients with immediate hypersensitivity diseases. Specifically, the present invention relates to a method for diagnosing of the diseases by detecting of the immune complex. More specifically the present invention includes the discovery of antitryptase autoantibody-tryptase immune complex in anaphylaxis sera and establishment of enzyme linked immunosorbent assays (ELISA) for detection of the antitryptase autoantibody-mast cell tryptase immune complex in sera of patients with anaphylaxis. The immune complexes can be used as a target for therapy of the immediate hypersensitivity diseases. The pathophysiological mechanism is provided.
Dr. William M Pandak, Richmond VA - MD (Doctor of Medicine)
Dr. William M Pandak, Richmond VA - MD (Doctor of Medicine)
Specialties:
Gastroenterology
Address:
Mcguire VA Med Ctr Gastrontlgy
1201 Broad Rock Blvd SUITE 111-N, Richmond 23249
(804) 675-5021 (Phone)
1201 Broad Rock Blvd SUITE 111-N, Richmond 23249
(804) 675-5021 (Phone)
Certifications:
Gastroenterology, 2002, Internal Medicine, 1986
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Virginia Commonwealth University / Medical College of Virginia School of Medicine
Graduated: 1983
Virginia Commonwealth University Medical Center
Virginia Commonwealth University / Medical College of Virginia School of Medicine
Graduated: 1983
Virginia Commonwealth University Medical Center
William Michael Pandak, Richmond VA
William Michael Pandak, Richmond VA
Specialties:
Gastroenterologist
Address:
1201 Broad Rock Blvd, Richmond, VA 23249
Veterans Affairs Medical Center &Amp; Va Commonwealth U, Richmond, VA 23249
1200 E Broad St, Richmond, VA 23298
Veterans Affairs Medical Center &Amp; Va Commonwealth U, Richmond, VA 23249
1200 E Broad St, Richmond, VA 23298
Education:
Medical College of Virginia - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Gastroenterology (Internal Medicine)
William Pandak, Richmond VA
William Pandak, Richmond VA
Specialties:
Internal Medicine, Gastroenterology
Work:
Hunter Holmes Mcguire Va Medical Center
1201 Broad Rock Blvd, Richmond, VA 23286 VCU Health System
Medical College Of Virginia, Richmond, VA 23219 Ambulatory Care Center
417 N 11Th St, Richmond, VA 23298 VCU Health System
1250 E Marshall St, Richmond, VA 23298
1201 Broad Rock Blvd, Richmond, VA 23286 VCU Health System
Medical College Of Virginia, Richmond, VA 23219 Ambulatory Care Center
417 N 11Th St, Richmond, VA 23298 VCU Health System
1250 E Marshall St, Richmond, VA 23298
Education:
Virginia Commonwealth University (1983)
Nuclear Sulfated Oxysterol, Potent Regulator Of Lipid Homeostasis, For Therapy Of Hypercholesterolemia, Hypertriglycerides, Fatty Liver Diseases, And Atherosclerosis
Nuclear Sulfated Oxysterol, Potent Regulator Of Lipid Homeostasis, For Therapy Of Hypercholesterolemia, Hypertriglycerides, Fatty Liver Diseases, And Atherosclerosis
US Patent:
2010027, Oct 28, 2010
Filed:
Feb 19, 2010
Appl. No.:
12/708803
Inventors:
Shunlin Ren - Richmond VA, US
William M. Pandak - Richmond VA, US
William M. Pandak - Richmond VA, US
International Classification:
A61K 31/575, C07J 9/00, A61P 3/06, A61P 9/10, A61P 1/16, A61P 7/00, A61P 29/00, C12N 5/00
US Classification:
514182, 552546, 435375
Abstract:
The sulfated oxysterol 5-cholesten-3β, 25-diol 3-sulphate, a nuclear cholesterol metabolite that decreases lipid biosynthesis and increases cholesterol secretion and degradation, is provided as an agent to lower intracellular and serum cholesterol and/or triglycerides, and to prevent or treat lipid accumulation-associated inflammation and conditions associated with such inflammation. Methods which involve the use of this sulfated oxysterol to treat conditions associated with high cholesterol and/or high triglycerides and/or inflammation (e.g. hypercholesterolemia, hypertriglyceridemia, non-alcoholic fatty liver diseases, atherosclerosis, etc.) are also provided.
Nuclear Sulfated Oxysterol, Potent Regulator Of Lipid Homeostasis, For Therapy Of Hypercholesterolemia, Hypertriglycerides, Fatty Liver Diseases, And Atherosclerosis
Nuclear Sulfated Oxysterol, Potent Regulator Of Lipid Homeostasis, For Therapy Of Hypercholesterolemia, Hypertriglycerides, Fatty Liver Diseases, And Atherosclerosis
US Patent:
2013014, Jun 6, 2013
Filed:
Feb 14, 2013
Appl. No.:
13/766839
Inventors:
Virginia Commonwealth University - Richmond VA, US
William M. Pandak - Richmond VA, US
William M. Pandak - Richmond VA, US
Assignee:
VIRGINIA COMMONWEALTH UNIVERSITY - Richmond VA
International Classification:
C07J 31/00
US Classification:
514182, 435375
Abstract:
The sulfated oxysterol 5-cholesten-3β, 25-diol 3-sulphate, a nuclear cholesterol metabolite that decreases lipid biosynthesis and increases cholesterol secretion and degradation, is provided as an agent to lower intracellular and serum cholesterol and/or triglycerides, and to prevent or treat lipid accumulation-associated inflammation and conditions associated with such inflammation. Methods which involve the use of this sulfated oxysterol to treat conditions associated with high cholesterol and/or high triglycerides and/or inflammation (e.g. hypercholesterolemia, hypertriglyceridemia, non-alcoholic fatty liver diseases, atherosclerosis, etc.) are also provided.